PUBLISHER: The Business Research Company | PRODUCT CODE: 2098808
PUBLISHER: The Business Research Company | PRODUCT CODE: 2098808
A digital pathology slide scanner is a medical imaging device that transforms physical glass pathology slides into high-resolution digital images. It employs advanced optical systems and scanning technologies to capture detailed tissue structures at multiple magnification levels for examination. These digital slides can subsequently be stored, shared, and reviewed on computer systems to assist in diagnosis, research, and remote pathology workflows.
The primary product types of digital pathology slide scanners include brightfield, fluorescence, and other product categories. Brightfield scanners are designed to capture standard stained tissue slides used for routine pathological examination and diagnosis. These systems utilize technologies such as whole slide imaging, live view scanning, z-stack scanning or focus stacking, confocal scanning, and other imaging techniques, and are categorized based on slide capacity into low-capacity scanners, medium-capacity scanners, and high-capacity scanners. The applications include disease diagnosis, academic research, drug discovery, and others, and they are used by end users such as hospitals, diagnostic laboratories, academic and research institutes, pharmaceutical companies, and biotechnology companies.
Tariffs are influencing the digital pathology slide scanner market by increasing the cost of imported high-precision optics, imaging sensors, and semiconductor components required for whole-slide imaging systems. This is causing procurement delays and raising capital expenditure for hospitals, diagnostic laboratories, and research institutes, particularly in import-dependent regions such as Asia-Pacific and parts of Europe. Hardware-intensive segments, including high-throughput scanners and advanced fluorescence imaging systems, are most affected due to their reliance on global supply chains. However, tariffs are also driving local manufacturing initiatives, regional supplier diversification, and increased investment in domestic digital pathology ecosystems, supporting long-term market resilience.
The digital pathology slide scanner market size has grown rapidly in recent years. It will grow from $1.04 billion in 2025 to $1.16 billion in 2026 at a compound annual growth rate (CAGR) of 11.6%. The growth in the historic period can be attributed to dependency on manual microscopy-based diagnosis, limited storage and archival capacity for glass slides, low scanner resolution and high equipment costs, slow adoption of digital laboratory systems, and shortage of skilled pathology workforce in remote regions.
The digital pathology slide scanner market size is expected to see rapid growth in the next few years. It will grow to $1.82 billion in 2030 at a compound annual growth rate (CAGR) of 11.8%. The growth in the forecast period can be attributed to rising adoption of telepathology, increasing demand for precision medicine diagnostics, expansion of hospital laboratory automation, growing need for data-driven diagnostic workflows, and increasing investment in cancer diagnostics infrastructure. Major trends in the forecast period include increasing adoption of remote pathology collaboration networks, rising demand for standardized digital slide archiving and retention compliance, expansion of high-throughput screening workflows in clinical pathology labs, growing emphasis on regulatory compliance and quality assurance in digital diagnostics, and increasing investment in ergonomic and user-friendly slide scanner hardware design.
The rising prevalence of cardiovascular diseases is expected to drive the growth of the digital pathology slide scanner market in the coming years. Cardiovascular diseases are disorders that affect the heart and blood vessels, including conditions such as coronary heart disease, stroke, heart failure, and arrhythmias. The increasing prevalence of cardiovascular diseases is being driven by aging populations, as advancing age significantly raises the risk of developing heart and vascular conditions, particularly among individuals over 65 years. Digital pathology slide scanners enable high-resolution digitization and analysis of tissue samples, supporting the detection of microscopic vascular and cardiac abnormalities with greater accuracy and improving diagnosis and research in cardiovascular diseases. For example, in October 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, cardiovascular disease accounted for 919,032 deaths in 2023, representing about one-third of all deaths. Coronary heart disease remained the most common type, with nearly one in six cardiovascular deaths occurring in adults under 65 years of age. Therefore, the rising prevalence of cardiovascular diseases is contributing to the growth of the digital pathology slide scanner market.
Major companies operating in the digital pathology slide scanner market are focusing on the development of advanced solutions such as whole-slide imaging systems to improve diagnostic accuracy, enable rapid high-resolution tissue analysis, and facilitate efficient digital workflow integration in pathology laboratories. Whole-slide imaging systems are digital pathology technologies that scan complete microscope slides at high resolution to generate detailed, navigable digital images for remote viewing, analysis, and diagnosis. For instance, in September 2024, Vieworks Co., Ltd., a South Korea-based bioimaging solutions company, introduced the LUCEON 510, an advanced digital pathology slide scanner. This system features a unique three-camera configuration that captures multiple focal plane images simultaneously, enabling four distinct imaging modes optimized for histopathology and cytology applications. The system delivers high-speed scanning performance while maintaining data efficiency comparable to single-camera systems, thereby improving workflow productivity and image accuracy. Additionally, it supports a wide range of sample types and enhances diagnostic precision through advanced imaging capabilities, making it suitable for both clinical and research settings.
In August 2025, Evident Corporation, a Japan-based medical imaging and life sciences company, acquired Pramana Inc. for an undisclosed amount. Through this acquisition, Evident aims to enhance its digital pathology capabilities by integrating Pramana's autonomous whole-slide imaging (WSI) technologies and AI-powered scanning systems, strengthening its digital pathology slide scanner portfolio and enabling high-throughput slide digitization, workflow automation, and advanced diagnostic imaging. Pramana Inc. is a US-based healthcare technology company specializing in fully autonomous digital pathology slide scanners and AI-enabled imaging systems used across hospitals, research laboratories, and academic institutions.
Major companies operating in the digital pathology slide scanner market are F. Hoffmann-La Roche AG, Danaher Corporation, Koninklijke Philips N.V., Evident Corporation, Nikon Corporation, Carl Zeiss AG, Hamamatsu Photonics K.K., Motic China Group Co. Ltd., OptraSCAN Inc., Morphle Labs Inc., Scopio Labs Ltd., 3DHISTECH Ltd., Vieworks Co Ltd, PreciPoint Group GmbH, Hangzhou KFBIO Biotechnology Co. Ltd., Huron Digital Pathology Inc., Mikroscan Technologies Inc., Paige.AI, Proscia Inc., Sectra AB, Indica Labs, Visiopharm.
North America was the dominant region in the digital pathology slide scanner market in 2025. Europe is expected to be the rapidly expanding region in the forecast period. The regions covered in digital pathology slide scanner report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the digital pathology slide scanner market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The digital pathology slide scanner market consists of revenues earned by entities by providing services such as whole slide imaging services, telepathology consultations, digital slide storage and management, and scanner maintenance and support services. The market value includes the value of related goods sold by the service provider or included within the service offering. The digital pathology slide scanner market also includes sales of whole slide imaging systems, automated slide scanners, image analysis software platforms, and digital pathology storage and management systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
The digital pathology slide scanner market research report is one of a series of new reports from The Business Research Company that provides digital pathology slide scanner market statistics, including digital pathology slide scanner industry global market size, regional shares, competitors with a digital pathology slide scanner market share, detailed digital pathology slide scanner market segments, market trends and opportunities, and any further data you may need to thrive in the digital pathology slide scanner industry. This digital pathology slide scanner market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Digital Pathology Slide Scanner Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses digital pathology slide scanner market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for digital pathology slide scanner ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The digital pathology slide scanner market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.